Found 6 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is C and Author is Lindblad, R  [Clear All Filters]
Conference Paper
R. Lindblad, Campanella, M., Van Veldhuisen, P., and Allen, C., “Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
S. H. Sicherer, Stablein, D., Wood, R. A., Burks, A. W., Liu, A. H., Jones, S. M., Fleischer, D. M., Mayer, L., Lindblad, R., Grishin, A., and Sampson, H. A., “Consortium of Food Allergy Research (CoFAR). Relationship of Cytokine and regulatory Gene Expression to the Outcomes of Milk and Egg Allergy in an Atopic Cohort.”, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 125, p. AB25.
Journal Article
D. McKenna, Adams, S., Sumstad, D., Sumstad, T., Kadidlo, D., Gee, A., Durett, A., Griffin, D., Donnenberg, A., Amrani, D., Livingston, D., Lindblad, R., Wood, D., and Styers, D., “CD34+ Cell Selection Using Small Volume Marrow Aspirates: A Platform for Novel Cell Therapies and Regenerative Medicine”, Cytotherapy, vol. 12, no. 2, pp. 170-177, 2010.
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., “Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology”, Contemp Clin Trials, vol. 34, pp. 196-204, 2013.
U. Ghitza, Gore-Langton, R., Lindblad, R., Shide, D., Subramanian, G., and Tai, B., “Common Data Elements for Substance Use Disorders in Electronic Health Records: The NIDA Clinical Trials Network Experience”, Addiction, vol. 108, pp. 3-8, 2013.
J. D. Lee, Jr, E. V. Nunes, Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, K. M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablien, D., Subramaniam, G., and Rotrosen, J., “Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial”, Lancet, 2017.